Article Information
History
- February 26, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- A Flora, MD1,2,3,
- EK Kozera, MD MPH MBeth1,2,
- R Jepsen, RN4,
- K Gill, MD Candidate3,
- J Xu, MD Candidate3 and
- JW Frew, MBBS(Hons) MMed MS PhD1,2,3,4,*
- 1Department of Dermatology, Liverpool Hospital, Sydney Australia
- 2Laboratory of Translational Cutaneous Medicine, Ingham Institute, Sydney, Australia
- 3University of New South Wales, Sydney, Australia
- 4Holdsworth House Medical Practice, Sydney, Australia
- ↵*Corresponding Author
Dr John W. Frew, Laboratory of Translational Cutaneous Medicine, Department of Dermatology, Liverpool Hospital, Suite 7, Level 1, 45-47 Goulburn St, Liverpool NSW 2170, Ph: +61 2 87384560, Fax: +61 2 87384639, Email: john.frew{at}unsw.edu.au
Posted February 26, 2023.
Baseline Clinical, Hormonal and Molecular Markers Associated with Clinical Response to IL-23 Antagonism in Hidradenitis Suppurativa: A Prospective Cohort Study
